trending Market Intelligence /marketintelligence/en/news-insights/trending/_8mwyuzpruh_e2q9wjoqjw2 content esgSubNav
In This List

Terumo devices used to treat brain aneurysms secure US FDA approval

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Terumo devices used to treat brain aneurysms secure US FDA approval

Terumo Corp., a Japanese medical technology company, won U.S. Food and Drug Administration premarket approval for its LVIS and LVIS jr. stents.

The tube-like devices are used in stent-assisted coil embolization of intracranial aneurysms, a life-threatening disorder of blood vessels in the brain in which weakness in the wall of a cerebral artery or vein causes a localized dilation or ballooning of the vessel.

LVIS and LVIS jr. are the only stents to get premarket approval from the FDA for the procedure.

Tokyo-based Terumo manufactures and sells medical devices and services and provides products for use in surgical procedures and transfusions.